| ID | Name | CAS | Properties |
logPoct/wat |
| 121-038-5 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-(2-ethylbutyl)-phosphorothioamidate
|
|
3 | 3.731 |
| 121-097-0 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, pentyl ester
|
|
3 | 5.310 |
| 121-247-3 |
Silane, methylvinyl(2,4,4-trimethylpentyloxy)(methylvinyl(2,4,4-trimethylpentyloxy)silyloxy)-
|
|
3 | 6.775 |
| 121-475-0 |
R,S-3',4'-methylenedioxy-«alpha»-pyrrolidinopropiophenone-M (desmethylene-oxo-), diethylated
|
|
3 | 2.678 |
| 121-496-7 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-(1-ethylpropyl)-phosphorothioamidate
|
|
3 | 3.484 |
| 121-625-3 |
3-Amino-3-(2-chlorophenyl)propionic acid, N-dimethylaminomethylene-, methyl ester
|
|
3 | 2.534 |
| 121-626-2 |
3-Amino-3-(4-fluorophenyl)propionic acid, N-dimethylaminomethylene-, methyl ester
|
|
3 | 2.020 |
| 121-701-8 |
Phosphonic acid, methyl-, o,o-bis-(3,3-dimethyl butyl) ester
|
|
3 | 4.715 |
| 121-783-8 |
1,3-Disiloxane, 1,3-dimethyl, 1,3-bis-(chloromethyl), 1,3-bis-(1-chloroethyl)
|
|
3 | 4.043 |
| 121-934-0 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N,N-dimethyl-phosphorothioamidate
|
|
3 | 2.267 |
| 121-994-4 |
2,5-Cyclohexadien-1-one, 2,6-dichloro-4-(chloroimino)-
|
101-38-2 |
3 | 2.409 |
| 122-066-3 |
3-Amino-2,3-dihydrobenzoic acid, N-dimethylaminomethylene-, butyl ester
|
|
3 | 2.175 |
| 122-067-2 |
3-Amino-2,3-dihydrobenzoic acid, N-dimethylaminomethylene-, ethyl ester
|
|
3 | 1.394 |
| 122-110-3 |
1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 8-chloro-1-phenyl-
|
22316-55-8 |
3 | 3.347 |
| 122-152-7 |
Methyl 5-«beta»-cholan-12-«alpha»-ol-3-one-24-oate, oxime, TMS # 1
|
|
3 | 8.272 |
| 122-270-6 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,5,6-trimethyl-7-phenyl
|
|
3 | 1.671 |
| 122-341-7 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, undecyl ester
|
|
3 | 5.952 |
| 122-342-6 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, tetradecyl ester
|
|
3 | 7.122 |
| 122-343-5 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, dodecyl ester
|
|
3 | 6.342 |
| 122-344-4 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, heptyl ester
|
|
3 | 4.391 |
| 122-346-2 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, nonyl ester
|
|
3 | 5.172 |
| 122-350-7 |
L-Proline, N-(2,6-difluoro-3-methylbenzoyl)-, pentadecyl ester
|
|
3 | 7.512 |
| 122-399-4 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, dodecyl ester
|
|
3 | 6.181 |
| 122-534-3 |
(1'S,3R,4a'S,5a'S,10a'S)-Methyl 1'-methyl-2-oxo-1',4a',5',5a',7',8',10',10a'-octahydrospiro[indoline-3,6'-pyrano[3,4-f]indolizine]-4'-carboxylate
|
5629-60-7 |
3 | 2.062 |
| 122-539-8 |
11H-Pyrido[2,1-b]quinazolin-11-one, 1,2,3,4,6,7,8,9-octahydro, 6-methyl
|
|
3 | 2.019 |
| 122-570-3 |
9-Methyl-6,7,8,9-tetrahydro-pyrido[ 2,1-b]quinazolin-11-one
|
|
3 | 2.134 |
| 122-615-3 |
1-(2-Methylbutoxy)-7-heptyl-2,2,4,4,6,6-hexamethyl-1,3,5,7-tetraoxa-2,4,6-trisilaheptane
|
|
3 | 6.175 |
| 122-640-5 |
5-methyl-2,3-bis(1'-pyrrolidinyl)-2-cyclopenten-1-one
|
|
3 | 1.998 |
| 122-767-5 |
3-[(Pyrrol1,1,3,3-tetramethyl-3-[(1-methylheptyl)oxy]disiloxanylmorphooxy)methyl]pyridine
|
|
3 | 5.394 |
| 122-840-3 |
Octahydrodipyrido[1,2-a:1',2'-d]pyrazine-6,12(2H,6aH)-dione
|
|
3 | 0.762 |
| 122-847-6 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, hexadecyl ester
|
|
3 | 7.742 |
| 122-923-1 |
trans-2-Hydroxycinnamic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
3 | 6.632 |
| 122-953-8 |
7-(Acetoxymethyl)-2,3,5,7a-tetrahydro-1H-pyrrolizin-1-yl tiglate
|
|
3 | 1.442 |
| 122-958-3 |
Androst-4-ene-3.alpha.,17.beta.-diol , per-TMS
|
|
3 | 7.389 |
| 122-964-6 |
Pyrrolidino[1,2-e]-4H-1,3,5-dithiolane, 2-butyl-4-methyl
|
|
3 | 3.751 |
| 123-105-8 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-(1-methylpropyl)-phosphorothioamidate
|
|
3 | 3.094 |
| 123-174-2 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-(1,1-dimethylethyl)-phosphorothioamidate
|
|
3 | 3.484 |
| 123-201-1 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, tetradecyl ester
|
|
3 | 6.961 |
| 123-559-5 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, hexadecyl ester
|
|
3 | 9.601 |
| 123-592-8 |
Cyclopentane-1,2-dione, 3,3,5,5-tetramethyl, bis(o-methyloxime)-(Z,Z)-
|
140401-51-0 |
3 | 2.447 |
| 123-631-4 |
Formosanan-16-carboxylic acid, 19-methyl-2-oxo-, methyl ester, (19«alpha»)-
|
509-80-8 |
3 | 2.062 |
| 123-653-0 |
2,4-Pregnadien-(2,3-d)isoxazol-17.alpha.-ethynyl-17.beta.-ol, TMS
|
|
3 | 6.080 |
| 123-686-4 |
3,5-Dihydroxybenzoic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
3 | 8.617 |
| 123-817-8 |
5,5-Diethyl-2-methyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 2.105 |
| 123-964-5 |
6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-one, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,8aS)-
|
510-77-0 |
3 | 2.058 |
| 123-994-2 |
1,3,2-Diazaphosphol-4-ene, 2-ethyl-1,3-dibutyl-4,5-dimethyl-
|
106054-01-7 |
3 | 4.787 |
| 124-022-9 |
5-«alpha»-Pregnan-3-«beta»,21-diol-20-one, MeTMS
|
|
3 | 7.286 |
| 124-026-5 |
2-Butenoic acid, 2-methyl-,8-methyl-6-(1-oxopropoxy)-8-azabicyclo[3.2.1]oct-3-yl ester, [1R-[1«alpha»,3«beta»(E),5«alpha»,6«alpha»]]-
|
54354-59-5 |
3 | 2.053 |
| 124-148-0 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,6-dimethyl-7-phenyl
|
|
3 | 1.329 |
| 124-159-8 |
3,4-Dihydroxybenzoic acid, bis(tert-butyldimethylsilyl) ether, tert-butyldimethylsilyl ester
|
|
3 | 8.617 |
| 124-238-0 |
N-(6-Methoxy-1,3-benzothiazol-2-yl)-2,2,3,3,3-pentafluoropropanamide
|
|
3 | 3.441 |
| 124-267-8 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-methyl-phosphorothioamidate
|
|
3 | 2.315 |
| 124-269-6 |
D-Pipecolic acid, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
3 | 2.585 |
| 124-293-9 |
Nicotinic acid, 1,2-dihydro-4,6-dimethyl-5-nitro-2-oxo-, ethyl ester
|
6972-37-8 |
3 | 0.595 |
| 124-317-2 |
Cyclopentane-1,2-dione, 3,3,5,5-tetramethyl, bis(o-methyloxime)-(E,Z)-
|
140210-45-3 |
3 | 2.447 |
| 124-391-0 |
2,6-Piperidinedione, 1-[(octahydro-2H-quinolizin-1-yl)methyl]-, (1R-cis)-
|
18688-40-9 |
3 | 1.790 |
| 124-453-1 |
1,3,2-Diazaphosphol-4-ene, 2-ethoxy-1,3-dibutyl-4,5-dimethyl-
|
|
3 | 4.719 |
| 124-523-3 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, hexyl ester
|
|
3 | 3.841 |
| 124-527-9 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, decyl ester
|
|
3 | 5.401 |
| 124-533-2 |
L-Proline, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, butyl ester
|
|
3 | 3.060 |
| 124-571-0 |
5-Methyl-9-azabicyclo[3.3.1]nonan-3-one, N-trifluoroacetyl
|
|
3 | 2.051 |
| 124-612-4 |
Pentan-2-one, 4-methyl-4-ethoxyamino, O-ethyloxime, syn
|
|
3 | 2.109 |
| 124-628-7 |
2-Nonenoic acid, 4-hydroxy, TMS, methyl ester, # 2
|
|
3 | 3.516 |
| 124-634-0 |
Pyrrolidin-2-one, 1-[1-(4-carbomethoxyphenyl)butan-1-ol-2-yl]-
|
|
3 | 1.908 |
| 124-641-2 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-isobutyl-phosphorothioamidate
|
|
3 | 2.951 |
| 124-647-6 |
Pregn-5-en-20-one, 3,16-bis[(trimethylsilyl)oxy]-, O-methyloxime, (3«beta»,16«alpha»)-
|
57305-31-4 |
3 | 7.638 |
| 124-670-0 |
2-Hydroxy-5-methoxybenzoic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
3 | 6.241 |
| 124-671-9 |
R,S-4'-Methoxy-«alpha»-pyrrolidinopropiophenone-M (desmethyl-3HO-), 2ET
|
|
3 | 3.151 |
| 124-692-6 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N,N-dimethyl-phosphorothioamidate
|
|
3 | 2.657 |
| 124-747-5 |
Benzenepropanoic acid, 3-methoxy-«alpha»,4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
55887-61-1 |
3 | 5.050 |
| 124-791-6 |
20.alpha.-hydroxy-pregn-4-en-3-one, MO-TMS, anti
|
|
3 | 6.808 |
| 124-793-4 |
6H-Pyrido[2,1-b]quinazolin-6-one, 7,8,9,10-tetrahydro-8-methyl
|
|
3 | 1.819 |
| 124-859-1 |
(E)-Methyl 2-((1'R,6'R,7'S,8a'S)-6'-ethyl-2-oxo-3',5',6',7',8',8a'-hexahydro-2'H-spiro[indoline-3,1'-indolizin]-7'-yl)-3-methoxyacrylate
|
76-66-4 |
3 | 3.350 |
| 124-895-1 |
11H-Pyrido[2,1-b]quinazolin-11-one, 1,2,3,4,6,7,8,9-octahydro, 9-methyl
|
|
3 | 2.019 |
| 124-907-7 |
11«alpha»,15«alpha»-dihydroxy-9-ketoprosta-5,13-dienoic acid, EO TMS # 2
|
|
3 | 9.086 |
| 124-968-0 |
Galanthan-1-ol, 3,12-didehydro-9,10-[methylenebis(oxy)]-, (1«alpha»)-
|
477-12-3 |
3 | 1.778 |
| 125-109-2 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, dodecyl ester
|
|
3 | 6.429 |
| 125-279-4 |
N,N-Dimethyl-N'-(3-methyl-2,6-dioxotetrahydro-2H-pyran-3-yl)imidoformamide
|
|
3 | 0.199 |
| 10-068-5 |
3«alpha»,6«alpha»,7«beta»,12«alpha»-Tetrahydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
2 | 9.945 |
| 10-210-6 |
2,2,4,6,8,10-hexamethyl-4,6,8,10-tetra(2-cyanoethyl)-[1,3,5,7,9,2,4,6,8,10]cyclopentasiloxane
|
|
2 | 4.728 |
| 10-421-2 |
5«beta»-Pregnane-3«alpha»,17«alpha»,20«alpha»-triol, (3,20-O)-diTBDMSi
|
|
2 | 9.561 |
| 10-423-0 |
5-«alpha»-Androst-1-ene-3-«beta»,17-«beta»-diol, TMS
|
|
2 | 7.245 |
| 10-453-7 |
5-[(1E)-3,3-dimethyl-1-triazenyl]-1h-imidazole-4-carbohydrazide
|
116401-55-9 |
2 | -0.908 |
| 10-635-5 |
2,2,4,4,6,8,8,10,12-nonamethyl-8,10,12-tri(2-cyanoethyl)-[1,3,5,7,9,11,2,4,6,8,10,12]cyclohexasiloxane
|
|
2 | 5.162 |
| 10-945-1 |
Formamide, n-benzyl-n-[3-benzyl-6-benzylamino-4-thioxo-5-pyrimidinyl]-
|
|
2 | 5.436 |
| 10-950-5 |
DL-3-Aminoisobutyric acid, N-(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 4.766 |
| 10-960-4 |
5«beta»-Androst-1-en-6«beta»-ol-3,17-dione,tris-TMS
|
|
2 | 8.326 |
| 11-040-4 |
6-Methyl, 2-methylmercapto-4-oxo-1,3,3a,7-tetrazaindene
|
|
2 | -0.034 |
| 11-047-7 |
ent-6-«alpha»,7-«alpha»,12-«alpha»-Trihydroxykaurenonic acid, methyl ester, TMS
|
|
2 | 7.619 |
| 11-078-3 |
Silane, (1,1-dimethylethyl)dimethyl[(6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-yl)oxy]-
|
61595-80-0 |
2 | 8.406 |
| 11-174-6 |
Silane, diphenyl(2,2,3,4,4,4-hexafluorobutoxy)hexyloxy-
|
|
2 | 5.392 |
| 11-193-5 |
(9E,12Z)-Tetradeca-9,12-dien-1-ol, tert-tert-butyldimethylsilyl ether
|
|
2 | 7.261 |
| 11-283-5 |
4-(4-Diethylamino-2-methylphenylimino)-1-oxo-N-phenyl-1,4-dihydro-2-naphthalenecarboxamide
|
|
2 | 5.723 |
| 11-348-3 |
Glucaric acid, 2,3,4,5-tetrakis-O-(trimethylsilyl)-, bis(trimethylsilyl) ester
|
38165-96-7 |
2 | 6.623 |
| 11-368-1 |
6.beta.-Hydroxy-3.alpha., 5.alpha.-cycloandrostan-17-one, TMS
|
|
2 | 7.204 |
| 11-373-5 |
Pentanoic acid, 2-[(tert-butyldimethylsilyl)oxy]-, tert-butyldimethylsilyl ester, (DL)-
|
|
2 | 5.725 |
| 11-605-7 |
D-Ribo-Hexonic acid, 3-deoxy-2,5,6-tris-O-(trimethylsilyl)-, lactone
|
55570-78-0 |
2 | 3.594 |
| 11-774-0 |
5-«beta»-Pregnan-3-«beta»-ol-11-one, MO-TMS
|
|
2 | 6.888 |
| 11-797-5 |
Silane, [[(3«alpha»,5«beta»,20S)-pregnane-3,17,20-triyl]tris(oxy)]tris[trimethyl-
|
17846-09-2 |
2 | 9.079 |
| 11-872-1 |
5-«alpha»-Pregnan-11-«beta»,20-«alpha»-diol-3-one, MO-TMS
|
|
2 | 7.718 |
|
« Previous Results
Next Results »
|